Wikidata

Q46619788: Difference between revisions

Browse history interactively
← Older edit
Daniel Mietchen (talk | contribs)
31,525,666 edits
‎Created claim: main subject (P921): patient (Q181600), #quickstatements; batch #6366 by User:Daniel Mietchen
‎Set a claim value: title (P1476): Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group
 
(10 intermediate revisions by 7 users not shown)
label / enlabel / en
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group.
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group
label / nllabel / nl
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group.
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group
description / ukdescription / uk
наукова стаття
наукова стаття, опублікована в травні 2008
Property / titleProperty / title
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group. (English)
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group (English)
Property / author name string
F Stephen Hodi
 
Property / author name string: F Stephen Hodi / rank
Normal rank
 
Property / author name string: F Stephen Hodi / qualifier
 
Property / author name string: F Stephen Hodi / reference
stated in: Europe PubMed Central
PubMed publication ID: 18445842
retrieved: 23 December 2017
Timestamp+2017-12-23T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

reference URL: http://europepmc.org/abstract/MED/18445842
 
Property / main subject
 
Property / main subject: dacarbazine / rank
 
Normal rank
Property / main subject: dacarbazine / reference
 
Property / language of work or name
 
Property / language of work or name: English / rank
 
Normal rank
Property / author
 
Property / author: F Stephen Hodi / rank
 
Normal rank
Property / author: F Stephen Hodi / qualifier
 
Property / author: F Stephen Hodi / qualifier
 
object named as: F Stephen Hodi
Property / author: F Stephen Hodi / reference
 
stated in: Europe PubMed Central
PubMed publication ID: 18445842
retrieved: 23 December 2017
Timestamp+2017-12-23T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

reference URL: http://europepmc.org/abstract/MED/18445842
Property / cites work
 
Property / cites work: Mutations of the BRAF gene in human cancer / rank
 
Normal rank
Property / cites work: Mutations of the BRAF gene in human cancer / reference
 
stated in: COCI
retrieved: 24 May 2022
Timestamp+2022-05-24T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

reference URL: https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE00766
Property / cites work
 
Property / cites work: Systemic treatments for metastatic cutaneous melanoma. / rank
 
Normal rank
Property / cites work: Systemic treatments for metastatic cutaneous melanoma. / reference
 
stated in: COCI
retrieved: 30 December 2023
Timestamp+2023-12-30T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

reference URL: https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001215
Retrieved from "https://www.wikidata.org/wiki/Q46619788"